Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Modulating glycolysis to improve cancer therapy
Cancer cells undergo metabolic reprogramming and switch to a 'glycolysis-
dominant'metabolic profile to promote their survival and meet their requirements for energy …
dominant'metabolic profile to promote their survival and meet their requirements for energy …
Targeting the Warburg effect in cancer: where do we stand?
I Barba, L Carrillo-Bosch, J Seoane - International Journal of Molecular …, 2024 - mdpi.com
The Warburg effect, characterized by the preferential conversion of glucose to lactate even
in the presence of oxygen and functional mitochondria, is a prominent metabolic hallmark of …
in the presence of oxygen and functional mitochondria, is a prominent metabolic hallmark of …
Selective autophagy in cancer: mechanisms, therapeutic implications, and future perspectives
J Liu, Y Wu, S Meng, P Xu, S Li, Y Li, X Hu, L Ouyang… - Molecular cancer, 2024 - Springer
Eukaryotic cells engage in autophagy, an internal process of self-degradation through
lysosomes. Autophagy can be classified as selective or non-selective depending on the way …
lysosomes. Autophagy can be classified as selective or non-selective depending on the way …
The regulation, function, and role of lipophagy, a form of selective autophagy, in metabolic disorders
S Zhang, X Peng, S Yang, X Li, M Huang, S Wei… - Cell death & …, 2022 - nature.com
Autophagy is a conserved method of quality control in which cytoplasmic contents are
degraded via lysosomes. Lipophagy, a form of selective autophagy and a novel type of lipid …
degraded via lysosomes. Lipophagy, a form of selective autophagy and a novel type of lipid …
[HTML][HTML] Targeting glucose metabolism enzymes in cancer treatment: current and emerging strategies
Simple Summary Reprogramming of glucose metabolism is a hallmark of cancer and can be
targeted by therapeutic agents. Some metabolism regulators, such as ivosidenib and …
targeted by therapeutic agents. Some metabolism regulators, such as ivosidenib and …
m6A-regulated tumor glycolysis: new advances in epigenetics and metabolism
SW Yue, HL Liu, HF Su, C Luo, HF Liang, BX Zhang… - Molecular cancer, 2023 - Springer
Glycolytic reprogramming is one of the most important features of cancer and plays an
integral role in the progression of cancer. In cancer cells, changes in glucose metabolism …
integral role in the progression of cancer. In cancer cells, changes in glucose metabolism …
Lipids in cancer: a global view of the contribution of lipid pathways to metastatic formation and treatment resistance
S Vasseur, F Guillaumond - Oncogenesis, 2022 - nature.com
Lipids are essential constituents for malignant tumors, as they are absolutely required for
tumor growth and dissemination. Provided by the tumor microenvironment (TME) or by …
tumor growth and dissemination. Provided by the tumor microenvironment (TME) or by …
Lipid droplets: a cellular organelle vital in cancer cells
Y **, Y Tan, J Wu, Z Ren - Cell death discovery, 2023 - nature.com
Lipid droplets (LDs) are cellular organelles comprising a core of neutral lipids (glycerides,
sterols) encased within a single phospholipid membrane, responsible for storing surplus …
sterols) encased within a single phospholipid membrane, responsible for storing surplus …
[HTML][HTML] Targeting the Warburg effect: A revisited perspective from molecular mechanisms to traditional and innovative therapeutic strategies in cancer
M Liao, D Yao, L Wu, C Luo, Z Wang, J Zhang… - … Pharmaceutica Sinica B, 2024 - Elsevier
Cancer reprogramming is an important facilitator of cancer development and survival, with
tumor cells exhibiting a preference for aerobic glycolysis beyond oxidative phosphorylation …
tumor cells exhibiting a preference for aerobic glycolysis beyond oxidative phosphorylation …
The Fibrillin‐1/VEGFR2/STAT2 signaling axis promotes chemoresistance via modulating glycolysis and angiogenesis in ovarian cancer organoids and cells
Z Wang, W Chen, L Zuo, M Xu, Y Wu… - Cancer …, 2022 - Wiley Online Library
Background Chemotherapy resistance is a primary reason of ovarian cancer therapy failure;
hence it is important to investigate the underlying mechanisms of chemotherapy resistance …
hence it is important to investigate the underlying mechanisms of chemotherapy resistance …